Baird lowered the firm’s price target on Synopsys (SNPS) to $630 from $644 and keeps an Outperform rating on the shares. The firm views the weakness in the shares following its results as a buying opportunity as the company offered positive views on EBIT margin improvement while the outlook for earnings and free cash flow generally matches expectations.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNPS:
- Synopsys Reports Strong 2024 Financial Results
- Synopsys (SNPS) Stock Falls 7% as Guidance Underwhelms
- Closing Bell Movers: Five Below up 13%, PVH slips 6% on earnings
- Synopsys falls 7% to $546.00 after issuing below-consensus Q1 guidance
- Synopsys sees FY25 operating cash flow ~$1.8B; free cash flow ~$1.6B